Literature DB >> 16334496

The influence of G-CSF addition to antibiotic treatment of experimental sepsis on pulmonary tissue.

Sevim Aydin1, Rahmet Caylan, Kemalettin Aydin, Esin Yulug, Engin Yenilmez, Iftihar Koksal.   

Abstract

AIM: To investigate the effects of G-CSF addition to antibiotic treatment of experimental sepsis on pulmonary lung tissue.
MATERIALS AND METHODS: Fifty Sprague-Dawley rats were used. The first four groups received a bolus intraperitoneal injection of Pseudomonas aeruginosa. The first group (Group SAG) received a combined therapy of imipenem and G-CSF, the second group (Group SA) received only imipenem, the third group (Group SG) received only G-CSF, and no antibiotic or G-CSF was given to the fourth group (Group S). The fifth group (Group C) served as the control. Survival rates, peripheral leukocyte counts (PLC) and absolute neutrophil counts (ANC) were obtained, and lung tissues were examined under light microscopy.
RESULTS: Survival rates at the 120th hour were 100% in groups SAG, SA and C; 20% in group SG; and 0% in group S. PLC and ANC values reached their highest levels at the 36th hour in the SAG group and at the 60th hour in the SA group. Pulmonary architecture was better preserved in the SAG, SA and SG groups--in that order--than in the S group.
CONCLUSION: Particularly in the early phase of infection, the administration of G-CSF in combination with antibiotics would be appropriate for maximizing the effect of antibiotics as soon as possible and for minimizing the damage caused by inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16334496      PMCID: PMC2594918     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  29 in total

1.  Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome.

Authors:  Yves Le Tulzo; Céllne Pangault; Arnaud Gacouin; Valérie Guilloux; Olivier Tribut; Laurence Amiot; Pierre Tattevin; Rémi Thomas; Renée Fauchet; Bernard Drénou
Journal:  Shock       Date:  2002-12       Impact factor: 3.454

2.  Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice.

Authors:  H Yasuda; Y Ajiki; T Shimozato; M Kasahara; H Kawada; M Iwata; K Shimizu
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

3.  Effect of teicoplanin and G-CSF on survival in experimental MRSA pneumonia in neutropenic mice.

Authors:  N Oz; C Agalar; C E Daphan; F Agalar; R Turkyilmaz
Journal:  Int J Surg Investig       Date:  2001

4.  Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats.

Authors:  Jay Steinberg; Jeffrey Halter; Henry J Schiller; Monica Dasilva; Steve Landas; Louis A Gatto; Paivi Maisi; Timo Sorsa; Minna Rajamaki; Hsi-Ming Lee; Gary F Nieman
Journal:  J Surg Res       Date:  2003-05-15       Impact factor: 2.192

5.  The genetic background of hypertensive, septic rats determines outcome improvement with antibiotic and G-CSF prophylaxis.

Authors:  Artur Bauhofer; Bjirn Tischer; Martin Middeke; Ulrike Plaul; Wilfried Lorenz; Alexander Torossian
Journal:  Shock       Date:  2003-10       Impact factor: 3.454

6.  The effect of granulocyte colony-stimulating factor in the treatment of Escherichia coli peritonitis with or without ceftriaxone in a nonneutropenic rat model.

Authors:  Rabin Saba; Muhsin Güler; Dilara Inan; Dilara Oğünç; Sakir Atalay; Latife Mamikoğlu; Filiz Günseren
Journal:  Surg Today       Date:  2003       Impact factor: 2.549

7.  Dependence of positive effects of granulocyte colony-stimulating factor on the antibiotic regimen: evaluation in rats with polymicrobial peritonitis.

Authors:  Artur Bauhofer; Alexander Torossian; Wilfried Lorenz; Martin Middeke; Ulrike Plaul; Philipp Schütz; Benno Stinner; Markus Hattel; Ilhan Celik
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

8.  Deleterious effects of mild hypothermia in septic rats are ameliorated by granulocyte colony-stimulating factor.

Authors:  Alexander Torossian; Sebastian Ruehlmann; Martin Middeke; Daniel I Sessler; Wilfried Lorenz; Hinnerk F Wulf; Artur Bauhofer
Journal:  Anesthesiology       Date:  2003-11       Impact factor: 7.892

Review 9.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

10.  In vivo activation of neutrophil function in hamsters by recombinant human granulocyte colony-stimulating factor.

Authors:  A M Cohen; D K Hines; E S Korach; B J Ratzkin
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

View more
  2 in total

Review 1.  Sepsis: in search of cure.

Authors:  Chikkamenahalli Lakshminarayana Lakshmikanth; Shancy Petsel Jacob; Vyala Hanumanthareddy Chaithra; Hugo Caire de Castro-Faria-Neto; Gopal Kedihithlu Marathe
Journal:  Inflamm Res       Date:  2016-03-19       Impact factor: 4.575

2.  Lactobacillus murinus alleviate intestinal ischemia/reperfusion injury through promoting the release of interleukin-10 from M2 macrophages via Toll-like receptor 2 signaling.

Authors:  Jingjuan Hu; Fan Deng; Bingcheng Zhao; Zebin Lin; Qishun Sun; Xiao Yang; Mei Wu; Shida Qiu; Yu Chen; Zhengzheng Yan; Sidan Luo; Jin Zhao; Weifeng Liu; Cai Li; Ke Xuan Liu
Journal:  Microbiome       Date:  2022-03-03       Impact factor: 14.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.